<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Portfolio Optimization | Hugo Academic CV Theme</title>
    <link>https://example.com/tags/portfolio-optimization/</link>
      <atom:link href="https://example.com/tags/portfolio-optimization/index.xml" rel="self" type="application/rss+xml" />
    <description>Portfolio Optimization</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Sat, 22 Mar 2025 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://example.com/media/icon_hu_645fa481986063ef.png</url>
      <title>Portfolio Optimization</title>
      <link>https://example.com/tags/portfolio-optimization/</link>
    </image>
    
    <item>
      <title>Pharmaceutical Industry Portfolio Optimization &amp; Risk Analysis</title>
      <link>https://example.com/project/healthcare-portfolio/</link>
      <pubDate>Sat, 22 Mar 2025 00:00:00 +0000</pubDate>
      <guid>https://example.com/project/healthcare-portfolio/</guid>
      <description>&lt;h2 id=&#34;project-overview&#34;&gt;Project Overview&lt;/h2&gt;
&lt;p&gt;This project examines the performance and risk profiles of leading pharmaceutical companies using a quantitative framework. By combining portfolio optimization techniques with CAPM analysis and non‐parametric risk assessments (such as Value at Risk and Expected Shortfall), the study aims to construct an optimized portfolio that maximizes risk‐adjusted returns while mitigating downside risks through diversification.&lt;/p&gt;
&lt;h2 id=&#34;data--methodology&#34;&gt;Data &amp;amp; Methodology&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;p&gt;&lt;strong&gt;Data Sources:&lt;/strong&gt;&lt;br&gt;
Financial data for major drug manufacturers (e.g., Pfizer, Johnson &amp;amp; Johnson, AbbVie) were obtained from public sources such as Yahoo Finance. The dataset spans multiple periods to enable comparison before and during market disruptions (e.g., COVID-19).&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;strong&gt;Data Preparation:&lt;/strong&gt;&lt;br&gt;
Raw data were cleaned to remove missing values and outliers, with appropriate transformations applied (e.g., conversion of categorical variables into dummy variables).&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;strong&gt;Modeling &amp;amp; Analysis:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Portfolio Optimization:&lt;/strong&gt;&lt;br&gt;
A tangency portfolio was constructed to maximize the Sharpe ratio, providing an “Optimal Portfolio” whose performance is compared against individual stocks.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;CAPM Analysis:&lt;/strong&gt;&lt;br&gt;
The Capital Asset Pricing Model (CAPM) was applied using market returns from the S&amp;amp;P 500 and a risk-free proxy from Treasury yields to estimate beta values.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Risk Metrics:&lt;/strong&gt;&lt;br&gt;
Non‐parametric methods were used to compute Value at Risk (VaR) and Expected Shortfall (ES) for both the 2017–2019 and 2020–2022 periods, illustrating changes in downside risk.&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;key-findings&#34;&gt;Key Findings&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Diversification Benefits:&lt;/strong&gt;&lt;br&gt;
The industry index shows lower volatility compared to individual stocks, demonstrating the risk-reducing effect of diversification.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Portfolio Performance:&lt;/strong&gt;&lt;br&gt;
The optimized portfolio achieves a higher Sharpe ratio than individual stocks, albeit with slightly higher volatility, which is acceptable given the improved risk-adjusted returns.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;CAPM Insights:&lt;/strong&gt;&lt;br&gt;
Beta estimates reveal that individual stocks vary in market sensitivity while the optimized portfolio maintains a near market-neutral position.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Risk Analysis:&lt;/strong&gt;&lt;br&gt;
The VaR and ES metrics highlight that, even during periods of increased market instability, the industry index remains the safest option.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;supporting-documents&#34;&gt;Supporting Documents&lt;/h2&gt;
&lt;p&gt;For further details on the analysis and methodology, please refer to the following documents:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/5630%20Project%20Presentation.pdf&#34;&gt;Project Presentation.pdf&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Project_final.pdf&#34;&gt;Code Output.pdf&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;repository-structure&#34;&gt;Repository Structure&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Reports &amp;amp; Presentations:&lt;/strong&gt;&lt;br&gt;
The main project report and presentation files outline the strategy, key backtest statistics, and visual summaries.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Python Notebook:&lt;/strong&gt;&lt;br&gt;
The code file includes the entire project including data sourcing, data cleaning, modeling, and visualizations.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;future-directions&#34;&gt;Future Directions&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Dynamic Rebalancing:&lt;/strong&gt;&lt;br&gt;
Investigate periodic rebalancing strategies to maintain optimal risk-adjusted returns.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Advanced Risk Metrics:&lt;/strong&gt;&lt;br&gt;
Incorporate additional metrics (such as the Calmar ratio) for a more comprehensive risk assessment.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Deployment:&lt;/strong&gt;&lt;br&gt;
Develop a dashboard or API for real-time monitoring and adjustment of the portfolio.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;conclusion&#34;&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;This analysis provides a robust quantitative framework for portfolio optimization in the pharmaceutical industry. By integrating CAPM analysis with non‐parametric risk assessments, the study offers actionable insights for constructing a diversified portfolio that minimizes downside risk while capturing excess returns.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Quant Strategy &amp; Portfolio Optimization Project</title>
      <link>https://example.com/project/quant_trading/</link>
      <pubDate>Sat, 22 Mar 2025 00:00:00 +0000</pubDate>
      <guid>https://example.com/project/quant_trading/</guid>
      <description>&lt;h2 id=&#34;project-overview&#34;&gt;Project Overview&lt;/h2&gt;
&lt;p&gt;This project develops a quantitative equity strategy that combines a long position based on growth and momentum with a short position driven by valuation and reversal signals. The aim is to construct a market-neutral portfolio that generates excess returns while minimizing systematic risk.&lt;/p&gt;
&lt;h2 id=&#34;strategy-description--rationale&#34;&gt;Strategy Description &amp;amp; Rationale&lt;/h2&gt;
&lt;h3 id=&#34;long-strategy-growth-and-momentum&#34;&gt;Long Strategy: Growth and Momentum&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Identify large-cap stocks with strong earnings growth and robust price momentum.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Method:&lt;/strong&gt;
&lt;ul&gt;
&lt;li&gt;Select stocks in the top 10th percentile for earnings growth over the past year.&lt;/li&gt;
&lt;li&gt;Among these, choose stocks with the highest percentage change in closing price within each industry.&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Rationale:&lt;/strong&gt; Companies exhibiting consistent financial improvement and price momentum are likely to continue their upward trend.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;short-strategy-pe-and-reversal&#34;&gt;Short Strategy: P/E and Reversal&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Short overvalued stocks that show signs of a downward trend.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Method:&lt;/strong&gt;
&lt;ul&gt;
&lt;li&gt;Screen for stocks with high P/E ratios in the top 20th percentile within their industry.&lt;/li&gt;
&lt;li&gt;Further filter for stocks whose closing price is below their 1-year moving average.&lt;/li&gt;
&lt;li&gt;Apply an RSI filter (RSI &amp;gt; 60) to capture overbought conditions.&lt;/li&gt;
&lt;/ul&gt;
&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Rationale:&lt;/strong&gt; Stocks that are overextended in price and underperforming relative to their valuation are likely to experience reversals.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;backtesting--portfolio-performance&#34;&gt;Backtesting &amp;amp; Portfolio Performance&lt;/h3&gt;
&lt;p&gt;The strategy was backtested using historical data, with key metrics summarized as follows:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Annualized Return:&lt;/strong&gt; 15.43%&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Annualized Standard Deviation:&lt;/strong&gt; 28.93%&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Annualized Sharpe Ratio:&lt;/strong&gt; 0.65&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Beta:&lt;/strong&gt; -0.07 (indicating near market neutrality)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Maximum Drawdown:&lt;/strong&gt; 46.17%&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;These results suggest that the portfolio achieves market neutrality and generates excess returns, with the long and short strategies effectively complementing one another.&lt;/p&gt;
&lt;h2 id=&#34;supporting-documents&#34;&gt;Supporting Documents&lt;/h2&gt;
&lt;p&gt;Below are direct links to the key files that support this analysis:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Backtest%20-%20Long.xls&#34;&gt;Backtest - Long.xls&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Backtest%20-%20Short.xls&#34;&gt;Backtest - Short.xls&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Portfolio.xlsx&#34;&gt;Portfolio.xlsx&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Quant%20Project%20Presentation.pptx&#34;&gt;Quant Project Presentation.pptx&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Quant%20Strategy%20Report.pdf&#34;&gt;Quant Strategy Report.pdf&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Screeners%20-%20Long.png&#34;&gt;Screeners - Long.png&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://example.com/uploads/Screeners%20-%20Short.png&#34;&gt;Screeners - Short.png&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;future-directions&#34;&gt;Future Directions&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Dynamic Rebalancing:&lt;/strong&gt; Explore periodic rebalancing strategies to adjust the portfolio in response to market changes.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Advanced Risk Metrics:&lt;/strong&gt; Incorporate additional metrics (e.g., Calmar ratio) for a more comprehensive risk assessment.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Deployment:&lt;/strong&gt; Develop an API or dashboard for real-time monitoring and adjustment of the strategy.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;conclusion&#34;&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;By combining a long strategy based on growth and momentum with a short strategy focused on valuation and reversal, this project demonstrates a robust approach to portfolio optimization and market neutrality. The backtesting results and supporting analyses provide valuable insights for constructing a diversified portfolio that effectively manages risk.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
